These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 20643648)

  • 1. Cardiac restricted overexpression of membrane type-1 matrix metalloproteinase causes adverse myocardial remodeling following myocardial infarction.
    Spinale FG; Mukherjee R; Zavadzkas JA; Koval CN; Bouges S; Stroud RE; Dobrucki LW; Sinusas AJ
    J Biol Chem; 2010 Sep; 285(39):30316-27. PubMed ID: 20643648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct regulation of membrane type 1 matrix metalloproteinase following myocardial infarction causes changes in survival, cardiac function, and remodeling.
    Zavadzkas JA; Mukherjee R; Rivers WT; Patel RK; Meyer EC; Black LE; McKinney RA; Oelsen JM; Stroud RE; Spinale FG
    Am J Physiol Heart Circ Physiol; 2011 Oct; 301(4):H1656-66. PubMed ID: 21666120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac-restricted overexpression of membrane type-1 matrix metalloproteinase in mice: effects on myocardial remodeling with aging.
    Spinale FG; Escobar GP; Mukherjee R; Zavadzkas JA; Saunders SM; Jeffords LB; Leone AM; Beck C; Bouges S; Stroud RE
    Circ Heart Fail; 2009 Jul; 2(4):351-60. PubMed ID: 19808359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanistic relationship between membrane type-1 matrix metalloproteinase and the myocardial response to pressure overload.
    Zile MR; Baicu CF; Stroud RE; Van Laer AO; Jones JA; Patel R; Mukherjee R; Spinale FG
    Circ Heart Fail; 2014 Mar; 7(2):340-50. PubMed ID: 24395927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity in MT1-MMP activity with ischemia-reperfusion and previous myocardial infarction: relation to regional myocardial function.
    Dixon JA; Gaillard WF; Rivers WT; Koval CN; Stroud RE; Mukherjee R; Spinale FG
    Am J Physiol Heart Circ Physiol; 2010 Dec; 299(6):H1947-58. PubMed ID: 20935147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TIMP2 deficiency accelerates adverse post-myocardial infarction remodeling because of enhanced MT1-MMP activity despite lack of MMP2 activation.
    Kandalam V; Basu R; Abraham T; Wang X; Soloway PD; Jaworski DM; Oudit GY; Kassiri Z
    Circ Res; 2010 Mar; 106(4):796-808. PubMed ID: 20056917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage overexpression of matrix metalloproteinase-9 in aged mice improves diastolic physiology and cardiac wound healing after myocardial infarction.
    Meschiari CA; Jung M; Iyer RP; Yabluchanskiy A; Toba H; Garrett MR; Lindsey ML
    Am J Physiol Heart Circ Physiol; 2018 Feb; 314(2):H224-H235. PubMed ID: 29030341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pressure overload-dependent membrane type 1-matrix metalloproteinase induction: relationship to LV remodeling and fibrosis.
    Zile MR; Baicu CF; Stroud RE; Van Laer A; Arroyo J; Mukherjee R; Jones JA; Spinale FG
    Am J Physiol Heart Circ Physiol; 2012 Apr; 302(7):H1429-37. PubMed ID: 22287584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac-restricted overexpression of extracellular matrix metalloproteinase inducer causes myocardial remodeling and dysfunction in aging mice.
    Zavadzkas JA; Plyler RA; Bouges S; Koval CN; Rivers WT; Beck CU; Chang EI; Stroud RE; Mukherjee R; Spinale FG
    Am J Physiol Heart Circ Physiol; 2008 Oct; 295(4):H1394-402. PubMed ID: 18689500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial overexpression of TIMP3 after myocardial infarction exerts beneficial effects by promoting angiogenesis and suppressing early proteolysis.
    Takawale A; Zhang P; Azad A; Wang W; Wang X; Murray AG; Kassiri Z
    Am J Physiol Heart Circ Physiol; 2017 Aug; 313(2):H224-H236. PubMed ID: 28550172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective spatiotemporal induction of matrix metalloproteinase-2 and matrix metalloproteinase-9 transcription after myocardial infarction.
    Mukherjee R; Mingoia JT; Bruce JA; Austin JS; Stroud RE; Escobar GP; McClister DM; Allen CM; Alfonso-Jaume MA; Fini ME; Lovett DH; Spinale FG
    Am J Physiol Heart Circ Physiol; 2006 Nov; 291(5):H2216-28. PubMed ID: 16766634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficiency of ataxia telangiectasia mutated kinase delays inflammatory response in the heart following myocardial infarction.
    Daniel LL; Daniels CR; Harirforoosh S; Foster CR; Singh M; Singh K
    J Am Heart Assoc; 2014 Dec; 3(6):e001286. PubMed ID: 25520329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of matrix metalloproteinases improves left ventricular function in mice lacking osteopontin after myocardial infarction.
    Krishnamurthy P; Peterson JT; Subramanian V; Singh M; Singh K
    Mol Cell Biochem; 2009 Feb; 322(1-2):53-62. PubMed ID: 18979185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted overexpression of tissue inhibitor of matrix metalloproteinase-4 modifies post-myocardial infarction remodeling in mice.
    Zavadzkas JA; Stroud RE; Bouges S; Mukherjee R; Jones JR; Patel RK; McDermott PJ; Spinale FG
    Circ Res; 2014 Apr; 114(9):1435-45. PubMed ID: 24637197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discordant activation of gene promoters for matrix metalloproteinases and tissue inhibitors of the metalloproteinases following myocardial infarction.
    Mukherjee R; Snipes JM; Saunders SM; Zavadzkas JA; Spinale FG
    J Surg Res; 2012 Jan; 172(1):59-67. PubMed ID: 20863528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of class I histone deacetylase activity represses matrix metalloproteinase-2 and -9 expression and preserves LV function postmyocardial infarction.
    Mani SK; Kern CB; Kimbrough D; Addy B; Kasiganesan H; Rivers WT; Patel RK; Chou JC; Spinale FG; Mukherjee R; Menick DR
    Am J Physiol Heart Circ Physiol; 2015 Jun; 308(11):H1391-401. PubMed ID: 25795711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accelerated LV remodeling after myocardial infarction in TIMP-1-deficient mice: effects of exogenous MMP inhibition.
    Ikonomidis JS; Hendrick JW; Parkhurst AM; Herron AR; Escobar PG; Dowdy KB; Stroud RE; Hapke E; Zile MR; Spinale FG
    Am J Physiol Heart Circ Physiol; 2005 Jan; 288(1):H149-58. PubMed ID: 15598866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted deletion of MMP-2 attenuates early LV rupture and late remodeling after experimental myocardial infarction.
    Hayashidani S; Tsutsui H; Ikeuchi M; Shiomi T; Matsusaka H; Kubota T; Imanaka-Yoshida K; Itoh T; Takeshita A
    Am J Physiol Heart Circ Physiol; 2003 Sep; 285(3):H1229-35. PubMed ID: 12775562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction.
    Doerries C; Grote K; Hilfiker-Kleiner D; Luchtefeld M; Schaefer A; Holland SM; Sorrentino S; Manes C; Schieffer B; Drexler H; Landmesser U
    Circ Res; 2007 Mar; 100(6):894-903. PubMed ID: 17332431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac-specific overexpression of diacylglycerol kinase zeta attenuates left ventricular remodeling and improves survival after myocardial infarction.
    Niizeki T; Takeishi Y; Arimoto T; Takahashi H; Shishido T; Koyama Y; Goto K; Walsh RA; Kubota I
    Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H1105-12. PubMed ID: 17071729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.